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Abstract
Metanephric kidney induction critically depends on mesenchymal–epithelial interactions in the caudal region of the nephric
(or Wolffian) duct. Central to this process, GDNF secreted from the metanephric mesenchyme induces ureter budding by
activating the Ret receptor expressed in the nephric duct epithelium. A failure to regulate this pathway is believed to be
responsible for a large proportion of the developmental anomalies affecting the urogenital system. Here, we show that the
nephric duct-specific inactivation of the transcription factor gene Gata3 leads to massive ectopic ureter budding. This
results in a spectrum of urogenital malformations including kidney adysplasia, duplex systems, and hydroureter, as well as
vas deferens hyperplasia and uterine agenesis. The variability of developmental defects is reminiscent of the congenital
anomalies of the kidney and urinary tract (CAKUT) observed in human. We show that Gata3 inactivation causes premature
nephric duct cell differentiation and loss of Ret receptor gene expression. These changes ultimately affect nephric duct
epithelium homeostasis, leading to ectopic budding of interspersed cells still expressing the Ret receptor. Importantly, the
formation of these ectopic buds requires both GDNF/Ret and Fgf signaling activities. We further identify Gata3 as a central
mediator of b-catenin function in the nephric duct and demonstrate that the b-catenin/Gata3 pathway prevents premature
cell differentiation independently of its role in regulating Ret expression. Together, these results establish a genetic cascade
in which Gata3 acts downstream of b-catenin, but upstream of Ret, to prevent ectopic ureter budding and premature cell
differentiation in the nephric duct.
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Introduction
In human, urinary tract anomalies rank among the most
common birth defects, with an estimated occurrence of 1 in 250
live births [1]. Most of these ontogenic malformations are classified
as Congenital Anomalies of the Kidney and Urinary Tract
(CAKUT) [2], which is a highly heterogenous condition frequently
diagnosed in combination with genital tract anomalies [3]. The
most relevant clinical manifestations include absent, dysplastic or
obstructed renal systems in infants as well as infertility, pregnancy
complications, hypertension and chronic renal failure in adults [4].
The development of the urogenital system (UGS) begins with
the formation of the nephric duct (or Wolffian duct) [5,6]. This
epithelial duct is a central UGS component among all vertebrates
and serves as the primordium for the ureter, kidney collecting duct
system and male genital tract [7]. Upon its induction in the
intermediate mesoderm at embryonic day (E) 8.5 in the mouse, the
nephric duct rapidly elongates caudally until it reaches the cloaca,
a pouch from which the bladder and urethra later develop. At
E10.5, the formation of the definitive (metanephric) kidney is
initiated by sprouting of the ureteric bud from the nephric duct
into the adjacent metanephric mesenchyme. The ureteric bud
subsequently undergoes several branching cycles to form the
collecting duct system, whereas the ureter tips induce nephron
formation in the surrounding mesenchyme [8].
Ureteric bud outgrowth and positioning are among the most
crucial steps of UGS development, since anomalies at the budding
stage account for the majority of kidney and urinary tract
developmental defects [9,10]. Extensive evidence has identified
GDNF/Ret signaling as a central regulator of ureteric bud
induction [11–16]. In this system, GDNF secretion in the
metanephric mesenchyme activates the Ret receptor tyrosine
kinase via its ligand binding GFRa1 co-receptor. In turn, Ret
activation results in the initiation of intracellular signaling
cascades, which mediate bud outgrowth, proliferation and
subsequent ureter branching. Understandably, the activity of
GDNF/Ret signaling is tightly regulated by various mechanisms to
allow for the generation of a single ureter at the appropriate
position [9]. In the mesenchyme surrounding the nephric duct, the
forkhead transcription factor FoxCI and the Slit2/Robo2 ligand-
receptor pair repress the rostral expression of GDNF [17,18],
while Bmp4 antagonizes its activity [19]. At the budding site,
PLoS Genetics | www.plosgenetics.org 1 December 2008 | Volume 4 | Issue 12 | e1000316Gremlin releases GDNF inhibition by Bmp4 [20], thereby
allowing ureteric bud outgrowth. In the nephric duct epithelium,
Sprouty1 protein function is crucial to negatively modulate Ret
signaling levels [21]. Of notice, gene mutations in any of these
regulators of GDNF/Ret signaling result in CAKUT-like
phenotypes in mice. In support of the clinical importance of these
genes, a growing number of them are found mutated in human
developmental diseases affecting the UGS [22–26].
Gata3 is a transcription factor of the Gata Zn-finger family,
which perform important functions during organogenesis [27]. In
humans, GATA3 haploinsufficiency causes hypoparathyroidism,
sensorineural deafness and renal anomalies (HDR) syndrome [28].
The urogenital defects of HDR patients closely resemble CAKUT
in combination with genital tract anomalies and include renal
aplasia, dysplasia, hypoplasia and vesicoureteral reflux [29,30].
Gene ablation studies in mice further revealed a critical role for
Gata3 in the development of several tissues [31,32]. In the
urogenital system, Gata3 is necessary for proliferation control and
guidance of the nephric duct [33]. Accordingly, it is the only Gata
factor expressed in this tissue prior to E12.5 [34].
Here we report the conditional inactivation of Gata3 specifically
in the nephric duct, at a stage past the developmental defects
observed in germline knockout embryos. These mice display
multiple UGS malformations affecting the kidney, ureter and
genital tracts. The detailed analysis of this phenotype reveals a
genetic cascade whereby b-catenin promotes Gata3 expression in
the nephric duct, which in turn activates Ret expression, maintains
an undiffererentiated epithelial cell state and prevents the
inappropriate response to signaling pathways promoting ureter
budding.
Results
Conditional Inactivation of Gata3 in the Urogenital
System
The strong mesonephric phenotype observed in Gata3
2/2
embryos [33] precludes the study of Gata3 function later during
urogenital system development. To investigate the role of Gata3 in
ureteric bud formation, we first generated a Gata3 conditional loss
of function allele (Figure 1A,B). For this, the parental Gata3 allele
(Gata3
ex4GFP) [33] was crossed with a transgenic strain expressing
FLPe in the germline [35] to excise the GFP-neo reporter cassette,
thereby generating a conditional Gata3 allele with loxP sites
flanking exon 4 (Gata3
flox). These mice were subsequently bred with
the More-Cre germline deleter strain [36] to generate the Gata3
D
allele in which exon 4 is removed. The splicing from exon 3 to
exon 5, expected from this modification, would generate a
frameshift leading to protein truncation just upstream of the first
zinc-finger DNA-binding domain. This gene mutation is therefore
predicted to be null, like other previously reported Gata3 mutant
alleles [32,33,37]. To delete Gata3 specifically in the maturing
nephric duct and derived collecting duct system, we crossed
Gata3
flox mice with the HoxB7-Cre mouse strain [38] to generate
HoxB7-Cre; Gata3
flox/D and HoxB7-Cre; Gata3
flox/flox embryos. Both
genotypes had the same phenotype and are subsequently referred
to as Gata3
ND2/2 embryos. Gata3
flox/flox, Gata3
flox/+ and HoxB7-Cre;
Gata3
flox/+ embryos failed to show any overt phenotype and were
used as controls.
Gata3
ND2/2 Embryos Show Multiple Urogenital System
Abnormalities
We initially characterized whole dissected urogenital systems
(UGS) of Gata3
ND2/2 embryos at embryonic day (E)18.5. This
gross analysis revealed a broad variety of malformations affecting
the kidneys and genital tracts. Kidney defects included agenesis
(15%), aplasia (20%) and severe dysplasia (65%) (Figure 2A–G).
Moreover, one third of the Gata3
ND2/2 embryos displayed duplex
kidneys (arrows in 2F). Histological analysis further revealed that
the dysplastic kidneys were associated with hydronephrosis and
hydroureter (Figure 2H,I). As expected from embryos with such
poor kidney endowment, no Gata3
ND2/2 pups could be recovered
after birth.
In addition to these renal defects, over 80% of male mutant
genital tracts displayed a massive enlargement of the vas deferens
in comparison to control embryos (Figure 2A,B,J,K). In female
embryos, Gata3 inactivation in the nephric duct resulted in a
complete loss of uterus in over 85% of UGSs examined. The
oviduct, however, was still present in these embryos
(Figure 2C,D,L,M). Hence the conditional inactivation of Gata3
leads to a broad spectrum of urogenital defects, including a high
incidence of hydronephrotic kidneys and hydroureters.
Multiple Ectopic Buds Are Observed in Gata3
ND2/2
Embryos
The combination of kidney hydronephrosis, hydroureter and
duplex kidneys seen in Gata3
ND2/2 embryos pointed to a primary
defect at the level of ureter budding. In order to easily visualize
nephric duct cells, we crossed the Rosa26
STOPLacZ allele [38] into
control and Gata3
ND2/2 genetic backgrounds and stained the
UGSs for b-Galactosidase activity.
During normal development, a localized swelling of the caudal
portion of the nephric duct indicates the site of ureteric bud
outgrowth at E10.5 (Figure 3A). The bud quickly emerges and
undergoes the first dichotomous branching event at E11.5,
forming the T-stage kidney (Figure 3C). Subsequently, the ureter
lengthens and multiple branching cycles mark the development of
the metanephric kidney (Figure 3E). In Gata3
ND2/2 mutant
embryos at E10.5, nephric duct swelling was sometimes observed
(Figure 3B), but normal ureteric bud formation failed in most
embryos analyzed. In addition, the nephric duct looked more
Author Summary
In humans, kidney development originates during embry-
onic development by the sprouting of an epithelial bud—
called the ureteric bud—from a simple epithelial struc-
ture—the nephric duct. The ureteric bud quickly grows
and branches in a treelike fashion to form the kidney
collecting duct system, while the emerging ureteric tips
induce nephron differentiation. One of the most important
steps during kidney development is the positioning of a
single ureteric bud along the nephric duct, since mutations
of genes implicated in this process lead to severe
urogenital malformations. In this study, we identified the
Gata3 protein as a crucial regulator of ureteric bud
positioning by using genetically modified mice. Deleting
the Gata3 gene in the mouse resulted in the development
of multiple kidneys emerging at improper positions. We
show that this defect was caused by a hypersensitivity of
nephric duct cells in their response to local growth signals.
Interestingly, this phenomenon was partly triggered by
premature differentiation of a subset of nephric duct cells.
Furthermore, we report a genetic pathway in which Wnt/b-
catenin signaling activates the Gata3 gene, which in turn
positively regulates the Ret gene. In summary, we
introduce a mouse model system that can be used to
study human birth defects affecting the urogenital system.
Gata3 in Ureteric Bud Induction
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epithelial buds formed along the entire length of the nephric duct,
with a preferential accumulation in the middle segments of the
duct (Figure 3D). By E12.5, the majority of the ectopic buds
started to regress, while some buds expanded to form ectopic
kidneys at a position far more rostral than the normal kidney
induction site (Figure 3F). Following ectopic bud regression, the
male nephric duct started to enlarge (Figure 4A,B) This was
accompanied by a slight increase of about 50% in cell proliferation
index, as determined by phospho-histone H3 immunolabelling at
E13.5 (Figure 4 C,D). In females, in situ hybridization with cRNA
probes against Emx2 and Wnt4, staining the Mu ¨llerian duct
epithelium and mesenchyme, respectively, revealed a block in
female genital tract elongation in the region where most ectopic
ureteric buds occurred (Figure 4E–H). Since the expression of the
key Mu ¨llerian duct regulators Wnt4, Emx2, Wnt9b and Lim1 was
Figure 1. Generation of a conditional Gata3 knockout allele. (A) The conditional Gata3 knockout allele was generated by crossing Gata3
ex4GFP
mice with FLPe germline deleter mice. The FLPe recombinase removed the Ires-GFP-neo cassette, thereby generating a Gata3 allele with loxP sites
flanking exon 4 (Gata3
flox). Subsequent crosses of Gata3
flox mice with More-Cre germline deleter mice resulted in Gata3-exon 4 excision and the
creation of a null allele (Gata3
D). (B) Representative genotyping by PCR for wild-type (+/+), Gata3
flox/flox (flox/flox) and Gata3
D/+ (D/+) mice prepared
from tail DNA.
doi:10.1371/journal.pgen.1000316.g001
Figure 2. Gata3
ND2/2 embryos display multiple urogenital system abnormalities. Urogenital systems were dissected at E18.5 and either
processed as whole mount (A–G) or subjected to H&E analysis on tissue sections (H–M). (A) Wild-type male UGS showing normal kidneys (k) and vas
deferens (vd). (B) UGS of a Gata3
ND2/2 male embryo, showing unilateral kidney agenesis (*), an aplastic kidney (ak) and bilateral vas deferens dilations
(white arrowheads). (C) Wild-type female UGS harboring a normal uterus (ut). (D) Female Gata3
ND2/2 UGS, with dysplastic kidneys (dk) and bilateral
agenesis of the uterus (white arrowheads point to remaining connective tissue). (E) Wild-type kidney and ureter. (F) Duplex kidneys and ureters (white
arrowheads) and (G) hydroureter, hydronephrosis and kidney dysplasia are frequently observed in conditional Gata3
ND2/2 embryos. (H, I) H&E
histological analysis of wild-type (H) and Gata3
ND2/2 (I) kidneys reveals severe kidney dysplasia and hydronephrosis affecting the collecting duct
system and all nephron segments. (J, K) Histological analysis of wild-type (J) and Gata3
ND2/2 (K) male genital tracts highlighting the dilated and fluid
filled vas deferens in mutant embryos. (L, M) H&E staining of wild-type (L) and Gata3
ND2/2 (M) female genital tract, confirming uterus agenesis (*) and
showing normal morphology of the ovaries (ov) and oviducts (od) in mutant embryos. cd, collecting duct; dt, distal tubule; g, glomerulus; pt, proximal
tubule.
doi:10.1371/journal.pgen.1000316.g002
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possible that this elongation defect is simply caused by a physical
obstruction by ectopic ureteric buds. Together, these results
indicate that the urogenital defects observed in Gata3
ND2/2
embryos are largely caused by the emergence of ureteric buds at
aberrant positions along the nephric duct.
The Formation of the Ectopic Buds Depends on GDNF/
Ret as well as Fgf Signaling
To determine the cause of ectopic ureter budding in
Gata3
ND2/2 embryos, we first looked at Ret expression by in situ
hybridization. Consistent with the previous analysis of Gata3
germline knockout embryos [33], most Gata3
ND2/2 nephric duct
cells lost Ret expression. Curiously, however, the ectopic buds of
Gata3
ND2/2 embryos remained positivefor Ret(Figure 5A,B).Insitu
hybridization with a cRNA probe against Gata3 exon 4 (which is
excised in the Gata3 conditional allele) confirmed that the bud cells
still expressed Gata3 (Figure 5C,D), whereas nephric duct cells had
already lost Gata3 expression (Figure 5C–F). The remaining Ret
expression therefore resulted from the incomplete action of Cre in
the nephric duct at this stage. Interestingly, these ectopic buds
consisted ofGata3+/Ret+ andGata32/Ret2 cellssegregated from
each other (Figure 5A–D). The continuous inactivation of Gata3 as
well as the downregulation of Ret expression was confirmed in
dysplastic Gata3
ND2/2 metanephric kidneys derived from such
ectopic buds (Figure 5G–J). The severity of kidney dysplasia in these
embryos correlated well with the amount of remaining Ret
expression (Figure 5J insert, data not shown). As expected, these
dysplastic kidneys additionally showed severely impaired nephron
differentiation, as evidenced by the strong reduction in Fgf8-positive
nephron precursors in comparison to control embryos
(Figure 5K,L).
Since Ret expression was specifically localized in the ectopic
ureteric buds of Gata3
ND2/2 embryos (Figure 5A,B), we hypoth-
esized that Ret signaling might be causally involved in the budding
process. To investigate whether the ectopic buds required GDNF/
Ret signaling, we performed organ culture experiments with
dissected Gata3
ND2/2 and control UGSs starting at E10.5. After
42 hours in culture, their development progressed, forming either
T-stage metanephric kidneys in control UGSs or multiple ectopic
buds in Gata3
ND2/2 UGSs (Figure 6A,B). Interestingly, addition of
the Ret tyrosine kinase inhibitor SU5416 [39] efficiently
suppressed ectopic budding in Gata3
ND2/2 UGSs in culture
Figure 3. Ectopic ureteric budding in Gata3
ND2/2 embryos. (A–F)
Dissected urogenital systems of control (HoxB7-Cre; Gata3
flox/+; Rosa26
S-
TOPlacZ/+)a n dGata3
ND2/2 (HoxB7-Cre; Gata3
flox/flox; Rosa26
STOPlacZ/+)
embryos were stained for b-Galactosidase activity at the indicated
embryonic stages. (A, B) Swelling of the caudal portion of the nephric
duct (nd) at E10.5 marks the ureteric bud induction site (ub) in control
and Gata3 mutant embryos. (C, D) At E11.5, the ureteric bud of control
embryos invades the metanephric mesenchyme to form a T-stage
kidney. In Gata3
ND2/2 embryos, ectopic buds form along the entire
length of the nephric duct (arrowheads). Gata3-deficient embryos
frequently fail to induce the primary bud (*). (E, F) At E12.5 the
metanephric kidney (k) undergoes its third round of branching
morphogenesis in control embryos. In Gata3
ND2/2 embryos, some
ectopic buds give rise to ectopic kidneys (ek) showing deficient
branching morphogenesis, whereas the most rostral buds start to
regress. Note the aberrant branch point of the ectopic kidneys (red
arrowhead).
doi:10.1371/journal.pgen.1000316.g003
Figure 4. Genital tract anomalies in Gata3
ND2/2 embryos. (A, B) b-Galactosidase staining of E14.5 genital ridges marks the beginning of
Wolffian duct hyperplasia in male Gata3
ND2/2 embryos (red arrowhead in B). (C, D) Immunostainings for the mitosis marker phosphorylated Histone
H3 (p-H3) show an increase in cell proliferation (n=4, P=0.09, Student’s t-test) in Gata3
ND2/2 nephric ducts at E13.5. E-cadherin labeling marks the
genital tracts. (E–H) Whole-mount in situ hybridizations for Emx2 (E, F) or Wnt4 (G, H) of control and Gata3
ND2/2 E13.5 genital ridges reveal an arrest
of Mu ¨llerian duct elongation (red arrowhead in F, H) in Gata3
ND2/2 embryos. Notably, the elongation arrest occurs at the level of persisting ectopic
ureteric buds (black arrows in B). nd, nephric duct; md, Mu ¨llerian duct; k, kidney; g, gonad.
doi:10.1371/journal.pgen.1000316.g004
Gata3 in Ureteric Bud Induction
PLoS Genetics | www.plosgenetics.org 4 December 2008 | Volume 4 | Issue 12 | e1000316(Figure 6D) as well as primary ureteric bud formation in control
UGSs (Figure 6C,D). To further assess the role of GDNF/Ret
signaling in ectopic bud formation, we treated cultured UGSs with
recombinant GDNF [40]. This treatment, sufficient to induce
ectopic budding in control UGS cultures (Figure 6E), significantly
increased the size of ectopic buds in Gata3-deficient cultures
(Figure 6F, compare with 6B). In addition, an antibody blocking
GDNF activity successfully inhibited both primary and ectopic
bud formation in control and Gata3
ND2/2 UGS cultures,
respectively (Figure G,H), thereby demonstrating the direct
implication of GDNF/Ret signaling in ectopic ureteric bud
formation. Interestingly, a 50% lower concentration of GDNF
blocking antibody still inhibited primary bud induction but failed
to inhibit the formation of ectopic buds (data not shown),
suggesting the presence of additional factors involved in the
budding process. One candidate is the Fgf signaling pathway,
which has the potential to induce ectopic ureter budding [41,42].
Supplementing the culture medium with a soluble FgfR2-Fc
chimeric protein [43] did not perturb primary ureteric bud
outgrowth in control cultures (Figure 6I). In striking contrast,
however, it could efficiently suppress ectopic ureter budding in
Gata3
ND2/2 cultures (Figure 6J). In conclusion, these results
demonstrate that the generation of the ectopic buds in Gata3
ND2/2
embryos is mediated through the combined action of GDNF and
Fgf signaling activities.
Molecular Characterization of Ectopic Ureteric Bud
Formation in Gata3
ND2/2 Embryos
To study ectopic bud formation at the molecular level, we
looked at the expression of key components of the GDNF/Ret
signaling cascade in E10.5 and E11.5 embryos. Already at E10.5,
prior to budding, Ret expression was lost in a subset of nephric duct
cells in Gata3
ND2/2 embryos (Figure 7A,B). Staining of adjacent
sections with a GDNF in situ probe revealed that the remaining
Ret-expressing cells were concentrated near the mesenchymal
source of GDNF (Figure 7C,D). At E11.5, only the caudal ectopic
buds that could maintain GDNF and Pax2 expression in the
surrounding mesenchyme were able to develop into ectopic
kidneys (Figure 7E,F and data not shown). In some Gata3
ND2/2
embryos, the forming buds induced more Wnt11 expression than
the presumptive ureteric bud induction site in control embryos,
pointing to an elevated GDNF/Ret signaling response in those
cells (Figure 7G,H). By E12.5, the expression of Wnt11 and Ret was
lost in the regressing ectopic buds of Gata3
ND2/2 embryos (data
not shown). Surprisingly, assessing the expression of the GDNF/
Ret modulators Spry1, Spry2, Spry4, Slit2, Robo2, FoxcI, FoxcII, Bmp4
and Grem1, only revealed a modest downregulation of Spry1 and
Slit2 expression in Gata3-mutant nephric duct cells at E10.5, while
the other markers remained unaffected (Figure 7I–L and data not
shown). In order to further support the involvement if Fgfs in
ectopic bud formation, we additionally probed control and
Gata3
ND2/2 embryos with the soluble Fgfr2-Fc fusion protein,
which recognizes several Fgfs [44]. This experiment revealed
strong and similar Fgf expression levels surrounding the nephric
duct in both Gata3-mutant and control embryos at E11.5
(Figure 7M,N). This protein localization was consistent with the
expression of one of the known FgfR2 ligands, Fgf10 (Figure 7O,P).
Hence, the molecular marker analysis reveals no obvious
mesenchymal defects, pointing to a primary defect in the response
of the nephric duct to GDNF and Fgf signals.
Figure 5. Gata3 is necessary for maintenance of Ret expression. (A–F) Gata3 maintains Ret expression in the nephric duct at E11.5. (A) Whole
mount in situ hybridization of control UGS with a Ret cRNA probe shows the smooth gradient of Ret expression along the entire length of the nephric
duct. (B) In Gata3
ND2/2 embryos, Ret expression is lost in most nephric duct cells except for some cells located in the ectopic ureteric bud tips
(arrows). (C,D) In situ hybridizations with a Gata3 cRNA probe specific for exon 4 confirm that the Ret expressing cells in the ectopic buds still express
Gata3. In these embryos, Gata3+ cells segregate from Gata32 cells. A similar tendency is observed in Gata3
ND2/2 embryos stained for b-
Galactosidase activity (D insert). (E, F) The caudal nephric duct efficiently deleted Gata3 already at this stage. (G–L) Deficient branching
morphogenesis and nephron differentiation in Gata3
ND2/2 hypodysplastic kidneys. (G,H) In situ hybridization with the Gata3-exon 4 cRNA probe
confirms Gata3 inactivation in Gata3
ND2/2 metanephric kidneys. (I, J) Ret expression becomes strongly downregulated in highly dysplastic Gata3-
mutant kidneys, in contrast to control kidneys. (J insert) Milder kidney dysplasia showing a pattern of Ret expression intermediate between wild-type
and highly dysplastic kidneys. (K,L) Fgf8 in situ hybridizations reveal impaired nephron induction in Gata3
ND2/2 kidneys. Tissue sections in D (insert)
and I–L are counterstained with nuclear fast red. nd, nephric duct; cl, cloaca; ut, ureter tip; rv, renal vesicle.
doi:10.1371/journal.pgen.1000316.g005
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ND2/2 embryos depends on GDNF/Ret and Fgf signaling. (A, B) E10.5 UGS organ cultures
recapitulate the phenotype of both control and Gata3
ND2/2 embryos observed in vivo. (C, D) Treatment of cultures with the Ret kinase inhibitor
SU5416 efficiently inhibits both primary (*) and ectopic budding in control and Gata3
ND2/2 UGSs. (E, F) Supplementing the organ cultures with
recombinant GDNF induces ectopic ureteric budding in control UGS cultures (arrows in E) and enhances ectopic bud growth in Gata3
ND2/2 UGS
cultures (arrows in F). (G, H) Organ culture of control or Gata3-deficient UGSs treated with a GDNF blocking antibody suppresses primary and ectopic
bud formation, respectively. (I, J) Soluble FgfR2-Fc fusion protein has no major effect on primary budding in control UGSs, but successfully inhibits
ectopic budding in Gata3
ND2/2 UGSs. ub, ureteric bud; *, primary bud agenesis.
doi:10.1371/journal.pgen.1000316.g006
Figure 7. Molecular characterization of ectopic ureteric bud formation in Gata3
ND2/2 embryos. (A, B) At E10.5 in Gata3
ND2/2 embryos, the
Ret+ nephric duct cells (nd) segregate from Ret2 cells prior to budding. (C,D) Adjacent sections show that Ret+ cells are localized next to GDNF
expressing cells in the metanephric mesenchyme (mm). (E, F) Ectopic kidneys (ek) maintain mesenchymal GDNF expression in the metanephric
mesenchyme at E11.5. (G, H) Induced ectopic ureteric buds in Gata3-deficient embryos strongly upregulate the expression of Wnt11 at E10.5. (I–L)
Slit2 and Spry1 are slightly downregulated in Gata3 mutant (nd) cells at E10.5. (M,N) FgfR2-Fc staining shows a strong but unaffected expression of
Fgf ligands in both control and Gata3
ND2/2 embryos at E11.5. (O,P) Fgf10 is expressed in the mesenchymal cells adjacent to the nephric duct in both
wild-type and Gata3
ND2/2 embryos. nd k: kidney, ur ureter.
doi:10.1371/journal.pgen.1000316.g007
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Nephric Duct
The developmental defects of Gata3
ND2/2 embryos described
above show striking similarities with the phenotypes resulting from
the conditional inactivation of b-catenin (ctnnb1) in the nephric duct
[45]. The fact that both animal models have the same spectrum of
genital tract and kidney defects, prompted us to verify whether
Gata3 and b-catenin act in the same genetic pathway. For this, we
first performed in situ hybridization against Gata3 in E11.5 HoxB7-
Cre; Ctnnb1
flox/2 embryos (Ctnnb1
ND2/2) and found a strong
downregulation of Gata3 expression in the nephric duct in
comparison to control embryos (Figure 8A,B). Accordingly, in
situ hybridizations with a Ret cRNA probe revealed a loss of Ret
expression in Ctnnb1
ND2/2 embryos (Figure 8C,D), which mimics
the loss of Ret expression in Gata3
ND2/2 embryos (Figure 5).
Staining of adjacent tissue sections with in situ probes for the
canonical Wnt target genes Axin2, Sp5 and Daple [46,47] confirmed
the loss of b-catenin transcriptional response in Ctnnb1
ND2/2
embryos (Figure 8E,F and data not shown). In order to clarify the
genetic hierarchy between Gata3 and b-catenin, we next stained
Gata3
ND2/2 embryos with antibodies against b-catenin and
phospho-b-catenin. These experiments failed to show any
modification of b-catenin expression levels or activity following
Gata3 inactivation (Figure 8G,H and data not shown). In support
of this, the expression of the canonical Wnt-signaling target genes
Axin2, Daple and Sp5 was unchanged in Gata3
ND2/2 embryos
(Figure 8I–L and data not shown). From these data, we conclude
that Gata3 acts genetically downstream of b-catenin but upstream of
Ret in the nephric duct. To further characterize the molecular basis
of the b-catenin-Gata3-Ret pathway, we first performed a bioinfor-
matics analysis of the 50 kb genomic region upstream of the mouse
and human Gata3 genes. Highly conserved sequences shared by
the two species were further analyzed for putative binding sites for
TCF/Lef. In total, 10 putative TCF/Lef binding sites, located in 5
of the 8 conserved regions, were identified (Figure 9A). In this
analysis, we additionally included a Gata3 urogenital enhancer
located at 2110 kb [48], but failed to detect any conserved TCF/
Lef binding sites in this element. A similar bioinformatics analysis
of the Ret regulatory region revealed putative Gata3 binding sites
in 4 of the 11 conserved regions 50 kb upstream of the Ret-ATG.
(Figure 9B). The potential of b-catenin to regulate endogenous
Gata3 expression was further evaluated in mouse IMCD3
collecting duct-derived cells. Using the GSK3b inhibitor BIO to
stabilize the b-catenin protein [49], we observed a significant
increase of Gata3 expression levels in those cells (Figure 9C). In
order to assess the activity of Gata3 on the Ret regulatory region,
we took advantage of the fact that one of the Gata3 binding sites
mapped to a region previously reported to drive reporter gene
expression in the zebrafish pronephros (Figure 9B, large asterisk)
[50]. To test whether Gata3 acts on this site, we isolated the 1.2 kb
conserved fragment and introduced a specific point mutation in
the Gata3 binding site (Figure 9B). The wild-type and mutated
fragments cloned upstream of a b-Gal reporter construct were
transfected in IMCD3 cells stably expressing Gata3. The
inactivation of the Gata3 binding site led to a significant
downregulation of b-Gal expression relative to the wild-type
control (Figure 9D), thereby suggesting that Gata3 may regulate
Ret expression directly from this binding site. Together these data
are consistent with a b-catenin-Gata3-Ret genetic cascade in the
nephric duct.
Premature and Ret-Independent Differentiation of Gata3
Mutant Cells
Another aspect of b-catenin-loss in the nephric duct is a
premature differentiation of the affected cells [45]. To test whether
this phenotype was also present in Gata3
ND2/2 embryos, we
stained mutant and control embryos with the differentiation
markers DBA and Zo1+. In the developing metanephric kidney,
DBA and Zo1+ are strongly expressed in the distal collecting duct
and downregulated in Ret+ ureter tip cells [45,51]. At E11.5, DBA
and Zo1+ expression were almost undetectable in the nephric duct
of control embryos (Figure 10A,B). However, Gata3-deficient cells
Figure 8. b-catenin regulates Gata3 expression in the nephric duct. (A, B) In situ hybridizations with a Gata3 cRNA probe reveal a strong
downregulation of Gata3 expression in the nephric duct of E11.5 Ctnnb1
ND2/2 embryos. (C, D) Likewise, in situ hybridizations with a Ret probe show a
strong decrease of Ret expression in Ctnnb1-deficient nephric ducts. (E, F) Adjacent sections stained for the b-catenin transcriptional target Axin2,
confirm loss of b-catenin signaling in Ctnnb1
ND2/2 embryos. (G,H) Phosphorylated b-catenin levels are not significantly perturbed in Gata3
ND2/2
embryos. E-cadherin was used as a nephric duct marker. (I–L) In situ hybridizations for Axin2 (I, J) and Daple (K, L) show a normal b-catenin signaling
response in Gata3
ND2/2 nephric ducts.
doi:10.1371/journal.pgen.1000316.g008
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suggesting a premature acquisition of a collecting duct identity in
these cells (Figure 10C,D). To clarify whether this premature
differentiation was a result of Gata3 inactivation only or secondary
to the loss of Ret expression in Gata3-mutant cells, we next tested
the expression of the two differentiation markers in Ret mutant
embryos. Interestingly, no difference in DBA and Zo1+ expression
levels could be observed between wild-type and Ret deficient
embryos (Figure 10A,B and E,F). To quantifiy the differentiation
defect in Gata3
ND2/2 embryos, we counted the total amount of
DBA-positive nephric duct cells in the three different genotypes.
Strikingly, we observed a ten-fold increase in differentiated nephric
duct cells in Gata3-deficient embryos when compared to control or
Ret mutant embryos (Figure 10G). From these data, we conclude
that Gata3 acts independently of Ret to maintain a precursor state
in the nephric duct epithelium, downstream of b-catenin.
Discussion
We previously reported the critical role played by Gata3 in
proliferation control and nephric duct guidance in the pro/
mesonephros [33]. To circumvent this early renal phenotype and
the embryonic lethality of Gata3
2/2 embryos at midgestation [31–
33], we generated a conditional knockout allele of Gata3. In order
to specifically address the later role of Gata3 in urogenital system
morphogenesis, we inactivated Gata3 in the nephric duct using the
HoxB7-Cre transgenic line (Gata3
ND2/2). This resulted in severe
malformations of the urogenital system including kidney agenesis,
aplasia, dysplasia, duplex systems, uterine agenesis and vas
deferens hyperplasia. This spectrum of malformations overlaps
with the urogenital phenotypes observed in HDR syndrome
patients (heterozygous for GATA3) and is generally reminiscent of
human congenital anomalies of the kidney and urinary tract
(CAKUT). Interestingly, most of these phenotypes can be either
directly or indirectly attributed to ectopic ureteric budding
observed in Gata3
ND2/2 embryos. Furthermore, our results
identify Gata3 as a critical mediator of b-catenin signaling, which
regulates both cell differentiation and Ret expression in the nephric
duct.
Regulation of Gata3 by b-Catenin
The UGS malformations observed in Gata3
ND2/2 embryos were
strikingly similar to the ones reported recently for Ctnnb1
ND2/2
embryos [45]. Gene expression analyses in both genotypes revealed
a genetic cascade whereby Gata3 acts downstream of b-catenin in the
nephric duct to maintain Ret expression and prevent premature
epithelial differentiation. These genetic interactions were further
supported by promoter analyses and cell culture assays. Hence, our
results identify Gata3 as a crucial mediator of b-catenin activity in
the nephric duct. Using Ret
2/2 embryos, we could further
determine that the premature differentiation phenotype observed
in Ctnnb1 and Gata3 mutant embryos is not mediated by Ret,
thereby establishing at least two distinct cellular functions regulated
by the b-catenin/Gata3 pathway (Figure 11A). The possibility
remains that b-catenin also has a Gata3-independent effect on Ret
expression. However, our data indicate that, if present, this effect is
not sufficient for Ret expression in the absence of Gata3.T h e
identification of b-catenin acting upstream of Gata3 also raises the
question of the transcriptional control of Gata3 expression in the
nephric duct. The only other regulators of Gata3 identified in this
tissue are the transcription factors Pax2 and Pax8 [33]. It is thus
possible that Pax2/8-mediated activation of Gata3 acts through the
b-catenin pathway. Alternatively, Pax2/8 and b-catenin may act
independently to regulate Gata3 expression in the nephric duct
either together or as activation and maintenance factors, respec-
tively. We favor the latter model based on the observation that the
canonical Wnt signaling readouts Axin2 and Daple are not yet
expressed in 18-somite stage embryos (E9.0; D.G., M.B. unpub-
lished results), whereas Gata3 is already under the control of Pax
genes at this stage [33]. The recent identification of a Gata3 kidney
enhancer active in the nephric duct may help clarify some aspects of
Gata3 regulation in this tissue [48].
Mechanisms of Ectopic Ureteric Bud Formation
Defects in ureteric budding account for most UGS defects in
humans and mice. The underlying cause is typically a deregulation
of GDNF/Ret signaling [9]. Accordingly, our data show a direct
implication ofGDNF/RetsignalingintheformationofGata3
ND2/2
ectopic buds. Recombinant GDNF treatment indeed sustained
ectopic bud growth in organ culture, while blocking the signaling
pathway with a GDNF blocking antibody or a chemical inhibitor
againstRetwassufficienttopreventectopicureterbudding.Wealso
demonstrated that the emerging buds consist of Ret+ cells, which
respond to mesenchymal GDNF by upregulating Wnt11 expression.
Importantly, however, we show that Ret expression was lost in
Gata3-mutant nephric duct cells and that these Gata32/Ret2 cells
failed to contribute to ectopic ureteric bud formation. This suggests
that ectopic ureteric buds form as a consequence of Gata3 loss in
Figure 9. In vitro analysis of the b-catenin-Gata3-Ret molecular
cascade. (A, B) Bioinformatic analysis of Gata3 and Ret genomic loci
50 kb upstream of the translational start site. Conserved regions
between mouse and human sequences are depicted as thick black lines.
Conserved TCF/Lef binding sites (consensus sequence (C/G)TTG(A/T)(A/
T)) [69] (A) and Gata3 binding sites (consensus sequence (A/T)GATA(A/
T)) [70] (B), are represented as asterisks. (B) A putative Gata3 binding
site located in a previously reported RET regulatory element [50] and
the mutated version used in (D) are indicated in brackets. (C)
Quantitative RT-PCR analysis of Gata3 expression in mIMCD3 reveals a
marked increase in endogenous Gata3 expression upon treatment with
3 mM BIO versus DMSO control. Results are expressed as ratios relative
to control (n=3, ** P,0.01, Student’s t-test). (D) b-Galactosidase
reporter activity is decreased in Gata3-expressing mIMCD3 cells
transfected with an expression construct containing the mutated Gata3
binding sequence (as indicated in B), when compared to the wild-type
control. Results are expressed as ratios relative to control. (n=3, *
P,0.05, Student’s t-test).
doi:10.1371/journal.pgen.1000316.g009
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signaling played a role in the segregation of Gata3+/Ret+ from
Gata32/Ret2 cells. Interestingly, a biased contribution of Ret+
and Ret2 cells was also observed in the ureteric bud and
metanephric kidney of embryos chimeric for the Ret gene [40].
However, the precise mechanism leading to Gata3+/Ret+ and
Gata32/Ret2 cell segregation remains unclear.
Importantly, a number of observations argue against a simple
GDNF/Ret-based budding mechanism. Among them are 1) the
different sensitivity of ectopic buds towards GDNF-blocking
antibody concentration and 2) the fact that ectopic buds emerge
in all directions whereas GDNF is expressed in the inner
intermediate mesoderm only. Together, these observations point
to the existence of a parallel pathway to GDNF/Ret promoting
ectopic ureter budding in Gata3
ND2/2 embryos. Using a soluble
recombinant Fgf receptor 2, we identified Fgf signaling as a crucial
component of this alternative pathway. In support of this, Fgfs are
able to induce ectopic budding in organ culture [41,42]. Of notice,
the RTK inhibitor (SU5416) we used to inhibit Ret signaling in
culture was also reported to have an effect on FgfRs [39], which
may have enhanced its activity against ectopic ureteric bud
formation.
The genetic regulation of Ret by Gata3 corroborates our
previous observations in germline Gata3 mutant embryos [33], but
raises the intriguing question of the relationship between Gata3+/
Ret+ budding cells and their surrounding Gata32/Ret2 cells in
ectopic ureteric bud formation. Remarkably, the expression of the
GDNF/Ret signaling regulators, Foxc1, Foxc2, Robo2, Bmp4, Grem1
and GDNF was not significantly affected in Gata3
ND2/2 embryos.
The modest dowregulation of Spry1 and Slit2 expression was
additionally restricted to non-budding Gata3-mutant cells and
might be secondary to the loss of Ret expression. Hence, none of
the major known mechanisms of GDNF/Ret modulation are
likely to cause ectopic ureter budding in Gata3
ND2/2 embryos.
Instead, this suggests that the juxtaposition of nephric duct cells
with different Gata3/Ret status is central to the ectopic budding
phenotype. Hence, the simplest model to explain ectopic ureteric
bud formation would be that the combined expression of GDNF
and Fgf along the defective Gata3
ND2/2 nephric duct at E10.5 is
Figure 10. Gata3 regulates cell differentiation in a Ret independent manner. (A,C) Co-immunostainings for b-catenin and Zo1+ reveal an
increase of Zo1+ expression in Gata3-deficient nephric ducts at E11.5. (B, D) Similarly, E-cadherin/DBA co-labeling shows stronger DBA staining in
Gata3
ND2/2 embryos. (E,F and A,B) No change in Zo1+ or DBA expression was observed between Ret
2/2 and control embryos at E11.5. The HoxB7-
driven Venus signal outlines the nephric duct. (G) Quantification of the DBA positive cells reveal a tenfold increase of DBA+ cells in Gata3
ND2/2
embryos when compared to control and Ret
2/2 embryos (n=4, P,0.001, Student’s t-test).
doi:10.1371/journal.pgen.1000316.g010
Figure 11. Summary of Gata3 function in progenitor cell state
maintenance in the nephric duct. (A) Genetic regulation experi-
ments with Gata3, b-catenin and Ret mutant embryos identify a cascade
whereby Gata3 acts downstream of the b-catenin developmental
program to independently maintain Ret expression and to prevent
premature differentiation of nephric duct cells. (B–D) Panel B- In wild-
type nephric duct cells, high levels of Gata3 expression maintain
nephric duct homeostasis. Panel C- A critical downregulation in Gata3
expression levels (dark blue cells) in Gata3
ND2/2 mice (and possibly also
in HDR-patients) causes an imbalance in the response to local growth
factors such as GDNF and Fgfs (green circles). This may come as a result
of premature cell differentiation and differential cell adhesion
properties of Gata3-deficient cells. Panel D- Consequently, cells with
sufficient levels of Gata3 (and Ret) segregate from Gata3-mutant cells
and expand, thereby forming ectopic buds and kidneys.
doi:10.1371/journal.pgen.1000316.g011
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duct cells. At E11.5, the source of GDNF becomes restricted to the
metanephric mesenchyme adjacent to the caudal region of the
nephric duct. Thus, only the ectopic buds which are close enough
to this mesenchymal source of GDNF and still harbor a sufficient
number of Ret+/Gata3+ cells will be able to sustain the GDNF/
Ret/Wnt11 positive feed back loop [52] and continue to grow to
form ectopic kidneys. At this stage, most of the rostral buds are
devoid of local GDNF expression and will therefore regress.
Importantly, the trigger for the aberrant responses to GDNF and
Fgf inductive signals necessarily results from the loss of Gata3 in the
surrounding nephric duct cells (Figure 11B). Ectopic budding may
thus be a consequence of the premature differentiation and changes
in adhesive properties observed in Gata3-mutant cells, as reported
for Ctnnb1
ND2/2 embryos [45]. Alternatively, the loss of Gata3 may
result in the activation of yet unidentified signals affecting the
behavior of neighboring cells (Figure 11B). By avoiding these
aberrant cellular responses in wild-type embryos, Gata3 maintains
epithelial homeostasis and thus prevents the formation of ectopic
buds by GDNF and Fgf in nephric duct regions that normally
express their respective receptor.
Gata3 and HDR Syndrome
In humans, heterozygous inactivation of the GATA3 gene is
responsible for HDR syndrome [28,30]. As many as 35 of the 38
mutations identified to date result in a loss of GATA3 DNA
binding activity, mostly as a consequence of complete gene
deletion or truncation of GATA3 DNA-binding domains [53]. As
in Gata3
ND2/2 embryos, this GATA3 haploinsufficiency in HDR
patients leads to a variety of UGS defects such as kidney agenesis,
dysplasia, hypoplasia, sometimes associated with female genital
tract malformations [29,30]. This suggests that a critical threshold
level of GATA3 is necessary to perform its normal function in the
UGS and that cells or tissues expressing GATA3 below this level
behave aberrantly. The Gata3 threshold is apparently reached at
50% gene dosage in human. Such a threshold, however, is not
observed in Gata3 heterozygous mice [32]. Instead, UGS
anomalies in mice are only observed at Gata3 expression levels
below 50% of the wild-type levels [48], complicating the use of
Gata3 mutant mice as disease models. The mosaic inactivation we
observe in Gata3
ND2/2 embryos may, in fact, better mimic the
threshold mechanism of HDR malformations whereby some cells
respond normally to Gata3 while others behave aberrantly. In this
respect, it is possible that the urogenital anomalies of HDR
patients are caused by premature nephric duct progenitor cell
differentiation and involve an aberrant response to GDNF and Fgf
signaling. Hence, the Gata3
ND2/2 embryos may provide a suitable
model to understand the molecular mechanisms and morphoge-
netic defects underlying HDR syndrome and other CAKUT-
related UGS diseases.
Materials and Methods
Mice
Conditional and germ-line Gata3 knockout mice were generated
by crossing Gata3
ex4GFP mice [33] with ACTB-FLPe [35] and More-
Cre [36] transgenic mice. The Gata3
flox and Gata3
D alleles were
genotyped using the primers 59-TATCAGCGGTTCATCTA-
CAGC and 59-TGGTAGAGTCCGCAGGCATT. HoxB7-Cre
and Rosa26
STOPlacZ [38,54] mice were purchased from The Jackson
Laboratory. All mice were kept in a pure C57BL/6 genetic
background. Mutant mice for Ctnnb1 [45] and Ret [16] were
generated as described. The HoxB7-Venus line will be reported
elsewhere.
In Situ Hybridization and Histology
Embryo dissections and processing as well as in situ hybridiza-
tion on whole mount embryos or tissue sections were performed as
described [55,56]. The Gata3-exon 4 probe was generated by PCR
amplification of the coding sequence of Gata3 exon 4 and
subsequent cloning into the pGEM-T-easy vector. The Daple
(Ccdc88c) in situ probe was transcribed from image clone 6408630
linearized at an internal Asp718 restriction site. The Emx2 [57]
Wnt4 [58], Ret [59], Gata3 [60], Axin2 [61], Fgf8 [62], GDNF [63],
Wnt11 [52], Slit2 [64], Spry1 [65] and Fgf10 [66] in situ probes
have been reported previously. Hematoxylin and eosin stainings
were performed on 6 mm-thick paraffin sections using standard
procedures.
Immunohistochemistry
Frozen sections have been prepared for immunohistochemistry
as described [67]. For immunostainings against b-catenin and
Zo1+, an antigen retrieval step has been included [45]. The
following antibodies and conjugates were used: rabbit anti-
phospho-H3 (1:200, Upstate Biotechnology), rat anti-E-cadherin
(1:400, Zymed Laboratories), mouse anti-b-catenin (1:400, Sigma),
rabbit anti-phospho-b-catenin (1:100, Cell signaling), rat anti-
Zo1+ (1:400, Chemicon), rabbit anti-GFP (1:1000, Abcam) and
biotinylated dolichos biflorus agglutinin (DBA) (1:500, Vector
Laboratories). Secondary detection was performed, using
Alexa488 or Alexa568 labeled anti-mouse, anti-rabbit or anti-rat
antibodies (1:200, Invitrogen). DBA-lectin staining was visualized
with FITC or Cy5 conjugated streptavidin (1:200, Zymed
Laboratories). FgfR2-ligand detection was performed on 12 mm
thick cryosections cut from freshly frozen unfixed embryos. After 3
washes in cold PBS, the slides were incubated for 1 hr at 4uCi n
blocking solution (10% normal goat serum, 2% BSA in PBS
supplemented with 0.5 mM MgCl2 and 1 mM CaCl2). The slides
were treated with 2.5 mg/ml mouse FgfR2-Fc (R&D systems) in
0.56blocking solution for 1 hr at 4uC. Following several washes in
PBS, the slides were fixed for 109 in 4%PFA. Subsequently, the
samples were handled as for standard immunohistochemistry.
Secondary detection was performed using a successive combina-
tion of biotinylated anti-human IgG (1:500, Vector Laboratories)
and streptavidin-FITC conjugate (1:200, Zymed Laboratories). All
slides were counterstained with 50 mg/ml DAPI and mounted
with Slow Fade Gold mounting medium (Invitrogen).
Organ Culture and b-Galactosidase Staining
Mouse urogenital ridges were micro-dissected in cold PBS
supplemented with 1% FBS, 1 mM CaCl2 and 0.5 mM MgCl2.
The ridges were collected into 10% FBS/DMEM medium
(Wisent) containing Penicillin/Streptomycin (Gibco) and L-
Glutamin (Gibco), preincubated at 37uCi n5 %C O 2 and kept
under these conditions until all ridges were dissected. Subsequent-
ly, the urogenital ridges were cultured in the presence of the
appropriate compound on 0.4 mm Transwell filters (Corning) at
37uCi n5 %C O 2 for 42 hrs. The following compounds were used:
rat recombinant GDNF (300 ng/ml, R&D systems) anti-GDNF
blocking antibody (10 or 20 mg/ml, R&D systems), SU5416
(20 mM, Calbiochem), IgG (20 mg/ml), FgfR2-Fc fusion protein
(20 mg/ml, R&D systems) or DMSO (0.01%, Fisher Scientific). b-
Galactosidase activity was detected by X-gal staining of dissected
or cultured urogenital ridges as described [68].
Cell Culture
Murine inner medullary collecting duct cells (mIMCD3, kindly
provided by Dr Paul Goodyer) were cultured in a 1:1 mix of DMEM
Gata3 in Ureteric Bud Induction
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serum. To induce the canonical Wnt-pathway, mIMCD3 cells were
stimulated with 3 mMB I O( ( 2 9Z,39E)-6-Bromoindirubin-39-oxime,
EMD) or 0.3% DMSO for 4 hours. RNA was extracted (Rneasy
Mini kit, Qiagen) and reverse transcribed (Superscript III, Invitrogen)
according to the manufacturer’s instructions. Quantitative PCR was
performed using iQ Sybr Green Supermix (BioRad) in a RealPlex
2
cycler (Eppendorf) using the following primers: Gata3 sense 59-
CTCTGGAGGAGGAACGCTAA-39 and antisense 59-
TTTGCACTTTTTCGATTTGC-39, S16 sense 59-GTACAAGT-
TACTGGAGCCTGTTTTG-39 and antisense 59-GCCTTTGA-
GATGGACTGTCGGATGG-39. For the production of mIMCD3
cells, stably overexpressing Gata3, mouse Gata3 cDNA was cloned
into pMSCV-HA3-IRES-GFP vector (kindly provided by Dr. Jerry
Pelletier). The Gata3-pMSCV vector was then co-transfected with
pVPack-GP and pVPack-VSV-G vectors (Stratagene) in HEK-293T
cells, for virus production. The virus containing supernatant was
harvested after 48 hrs by filtration and added to mIMCD3 cells.
48 hours post-infection, the cells were sorted according to GFP
expression on an FACSAria-sorter (BD-Bioscience). Gata3 expres-
sion levels were assessed by western blotting and the medium level
expressing cells were used for the subsequent b-Galactosidase
reporter analysis. The conserved RET regulatory element was
isolated from human RCC cells (ACHN) using published primers
[50] and subcloned into the pGEM-T-easy vector (Promega). The
point mutation in the Gata3 binding site was introduced via site-
specific mutagenesis using the overlap extension method. Subse-
quently, the wild-type and mutated element were cloned into the b-
Galactosidase expression vector pTrap [68] using the unique SalI,
SphI restriction sites. The pGAL4-SV40-Luc vector (kindly provided
by Dr. Xiang-Jiao Yang), constitutively expressing firefly luciferase,
was used as a transfection control. The Gata3 expressing mIMCD3
were transiently co-transfected with either the wild-type or mutated
pTrap vector in combination with pGAL4-SV40-Luc using
Lipofectamine 2000 (Invitrogen) according to manufacturer’s
instructions. The analysis was carried out 24 hours post-transfection
withtheDualLightCombined ReporterGeneAssaySystem(Applied
Biosystems)according tomanufacturer’sinstructions.All experiments
were done in triplicates.
Bioinformatics
The sequence alignments were performed, using blast2seq
(NCBI). The transcription factor binding sites were identified with
Mac Vector.
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